AVGR
- Avinger, Inc.
()
Overview
Company Summary
Avinger, Inc. is a medical device company specializing in the development and commercialization of image-guided, catheter-based systems for the treatment of various vascular diseases. The company primarily focuses on creating innovative solutions for complex peripheral artery disease (PAD), a condition that primarily affects the blood vessels outside the heart and brain.
Avinger's flagship product, called Pantheris, is an advanced image-guided atherectomy system. This device uses real-time intravascular imaging to offer physicians a high-resolution view of the inside of a patient's arteries, allowing for precise navigation and targeting of plaque build-up that causes blockages. It combines cutting and imaging capabilities into one catheter, enabling minimally invasive treatment of PAD without the need for open surgery.
The Pantheris system provides numerous benefits to both patients and doctors. By allowing physicians to see the inside of the arteries during a procedure, they can visualize and remove plaque in a more targeted and effective manner, minimizing the risk of complications and improving patient outcomes. Moreover, this technology reduces the need for invasive procedures, lengthy hospital stays, and recovery times, promoting faster patient recovery and reducing healthcare costs.
In addition to Pantheris, Avinger offers a range of complementary products and accessories designed to enhance the capabilities of their main device. These include the Lightbox imaging console, which provides high-quality imaging and real-time data analysis, and various catheters and guidewires used alongside Pantheris for specific procedures.
Avinger's innovative technologies have gained recognition within the medical community, and the company continues to invest in research and development efforts to expand its product portfolio and improve patient care. By focusing on the treatment of PAD and offering advanced, image-guided solutions, Avinger aims to positively impact the lives of millions of patients suffering from vascular diseases.